Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Rituximab Combined With Cyclosporine for Primary Membranous Nephropathy

NCT07861204 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07861204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Rituximab Combined With Cyclosporine for Primary Membranous Nephropathy
Lead sponsor
Peking University First Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 21, 2026
Completion date
December 30, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy